|
RPG Life Sciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
3795.70 Cr.
|
P/BV
|
6.59
|
Book Value (Rs.)
|
348.32
|
|
52 Week High/Low (Rs.)
|
2725/1733
|
FV/ML
|
8/1
|
P/E(X)
|
32.96
|
|
Bookclosure
|
27/06/2025
|
EPS (Rs.)
|
69.64
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 154.20 | 232.88 | 117.84 | 91.68 | 73.17 |
| | | | | | |
| Net CashFlow From Operating Activities | 56.50 | 77.86 | 94.36 | 90.82 | 64.75 |
| Net Cash Used In Investing Activities | 51.06 | -41.80 | -79.15 | -105.81 | -34.66 |
| Net Cash Used From Financing Activities | -20.58 | -27.08 | -20.31 | -17.13 | -13.51 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 86.98 | 8.98 | -5.10 | -32.12 | 16.58 |
| Cash And Cash Equivalents Begin of Year | 28.70 | 19.72 | 24.82 | 56.94 | 40.36 |
| Cash And Cash Equivalents End Of Year | 115.68 | 28.70 | 19.72 | 24.82 | 56.94 |